Europe's Open Search Market
This carefully selected group of stocks represents companies positioned to benefit from Google's changing search results in Europe. Our analysts have identified online travel, hotel, and local search businesses that could see increased visibility and traffic due to the EU's Digital Markets Act.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Booking Holdings Inc.
BKNG
Current price
$5,584.08
As a major online travel agency, Booking.com will benefit directly from more prominent placement in EU search results, potentially leading to increase...
As a major online travel agency, Booking.com will benefit directly from more prominent placement in EU search results, potentially leading to increased direct bookings.
TripAdvisor Inc
TRIP
Current price
$16.96
TripAdvisor's hotel booking and restaurant reservation services (TheFork) are direct competitors to Google's offerings and will gain visibility from t...
TripAdvisor's hotel booking and restaurant reservation services (TheFork) are direct competitors to Google's offerings and will gain visibility from the proposed changes.
Join Nemo FREE today and unlock every stock.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
The EU's Digital Markets Act is forcing Google to give rival services more prominence in search results. This creates a significant opportunity for companies that compete directly with Google's vertical search offerings, particularly in travel and local business listings.
What You Need to Know
This is an event-driven investment opportunity based on regulatory changes. The companies in this group could see increased web traffic, higher bookings, and improved market share as Google's dominance in European search results is balanced out.
Why These Stocks
We've selected companies whose core business models are directly positioned to benefit from these changes. Online travel agencies, hotel aggregators, and review sites stand to gain the most from increased visibility in Google's search results.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+37.54%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 37.54% over the next year.
Stocks Rated Buy by Analysts
10 of 15 assets in this group are rated Buy by professional analysts.
Group Growth
This group averaged a 1.7% return last month.
Why You'll Want to Watch These Stocks
Hidden Opportunity in Plain Sight
While most investors focus on tech giants, these companies are quietly positioned to benefit from one of Europe's biggest regulatory shifts. The Digital Markets Act could redirect millions of users to these platforms.
Travel's Digital Redirection
As Google's search results change, online travel companies could see significant traffic increases. More visibility often means more bookings, which could translate to stronger revenue growth.
Regulation Creating Opportunity
The EU's push for a more open digital marketplace is reshaping how users find travel and local businesses online. These companies are at the frontline of this shift, with potential for increased market share and growth.
Why Invest with Nemo Money!
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.